Syntheses of two isotopically labeled CB1 receptor antagonists |
| |
Authors: | Boris A. Czeskis |
| |
Affiliation: | Lilly Research Laboratories, Eli Lilly and Company, , Indianapolis, IN, 46285 USA |
| |
Abstract: | Synthesis of deuterium‐labeled CB1 receptor antagonist 2‐d9 was accomplished in three steps by alkylation of 2‐nitrophenylacetonitrile with cyclopentyl‐d9 bromide, reductive cyclization of the resulting secondary nitrile into the 3‐cyclopentyl indole‐d9 and its N‐sulfonylation with corresponding p‐amidosulfonyl chloride. Another, structurally related, CB1 receptor antagonist 1 was radiolabeled with carbon‐14 by oxidative cleavage of 3‐cyclopentyl indole followed by the ring closure of o‐acyl substituted N‐formylaniline with potassium cyanide‐[14C], in situ reduction‐elimination of the intermediate amino alcohol, and N‐sulfonylation of the resulting 3‐cyclopentyl indole‐2‐[14C]. |
| |
Keywords: | CB1 receptor antagonist 3‐cyclopentyl indole deuterium labeled carbon‐14 labeled |
|
|